sur OXURION (EBR:OXUR)
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
On August 28, 2026, Oxurion NV announced the receipt of a transparency notification from Atlas Special Opportunities II, LLC. According to the notification, as of August 5, 2026, Atlas held 28,009,477 shares, crossing under the 20% threshold of Oxurion's total outstanding shares, which numbered 140,734,891 at that time. This change was due to the sale of voting securities.
Oxurion, based in Leuven, Belgium, is listed on Euronext Brussels. The company focuses on building a technology-enabled clinical research and software platform. Their operations merge clinical expertise, software innovation, and proprietary data to aid various sponsors in pharmaceuticals, biotechnology, and medical devices.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de OXURION